Isoflavone and protein constituents of lactic acid-fermented soy milk combine to prevent dyslipidemia in rats fed a high cholesterol diet

Nutrients

Volumn 6, Issue 12, 2014, Pages 5704-5723

  Kobayashi, Maki ^a   Egusa, Shintaro ^b   Fukuda, Mitsuru ^c  

^a HYOGO UNIVERSITY   (Japan)

^b Marusan ai Co Ltd   (Japan)

^c MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cholesterol; Fermented soy milk; Isoflavone; Lipid metabolism; Soy protein

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL 7ALPHA MONOOXYGENASE; DAIDZEIN; DAIDZIN; FARNESOID X RECEPTOR; FATTY ACID SYNTHASE; FECES LIPID; GENISTEIN; GENISTIN; GLYCITEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; BIOLOGICAL MARKER; CHOLESTEROL INTAKE; ISOFLAVONE DERIVATIVE; LACTIC ACID; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CECUM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIETARY FIBER; DYSLIPIDEMIA; FAT INTAKE; GENE EXPRESSION; INTRAABDOMINAL FAT; LACTIC ACID FERMENTED SOYBEAN MILK; LACTOBACILLUS DELBRUECKII; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER WEIGHT; MALE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOYBEAN MILK; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHOLESTEROL INTAKE; COMPARATIVE STUDY; DAIRY PRODUCT; DISEASE MODEL; DYSLIPIDEMIAS; FERMENTATION; GENE EXPRESSION REGULATION; GENETICS; LACTOBACILLUS; LIPID DIET; LIVER; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BIOMARKERS; CHOLESTEROL, DIETARY; CULTURED MILK PRODUCTS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FERMENTATION; GENE EXPRESSION REGULATION; ISOFLAVONES; LACTIC ACID; LACTOBACILLUS; LIVER; MALE; RATS, SPRAGUE-DAWLEY; SOY MILK; SOYBEAN PROTEINS;

EID: 84916882961     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6125704     Document Type: Article

References (48)

1. Kannel, W.B.; Castelli, W.P.; Gordon, T.; McNamara, P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann. Intern. Med. 1971, 74, 1-12.
2. Ross, R.; Harker, L. Hyperlipidemia and atherosclerosis. Science 1976, 193, 1094-1100.
3. Meeker, D.R.; Kesten, H.D. Experimental atherosclerosis and high protein diets. Proc. Soc. Exp. Biol. Med. 1940, 45, 543-545.
4. Nagata, Y.; Ishiwaki, N.; Sugano, M. Studies on the mechanism of antihypercholesterolemic action of soy protein and soy protein-type amino acid mixtures in relation to the casein counterparts in rats. J. Nutr. 1982, 112, 1614-1625.
5. Yashiro, A.; Oda, S.; Sugano, M. Hypocholesterolemic effect of soybean protein in rats and mice after peptic digestion. J. Nutr. 1985, 115, 1325-1336.
6. Sugano, M.; Koba, K. Dietary protein and lipid metabolism: A multifunctional effect. Ann. N. Y. Acad. Sci. 1993, 676, 215-222.
7. Sugano, M.; Goto, S. Steroid-binding peptides from dietary proteins. J. Nutr. Sci. Vitaminol. 1990, 36, S147-S150.
8. Sugano, M.; Goto, S.; Yamada, Y.; Yoshida, K.; Hashimoto, Y.; Matsuo, T.; Kimoto, M. Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J. Nutr. 1990, 120, 977-985.
9. Carroll, K.K. Review of clinical studies on cholesterol-lowering response to soy protein. J. Am. Diet. Assoc. 1991, 91, 820-827.
10. Sirtori, C.R.; Lovati, M.R.; Manzoni, C.; Monetti, M.; Pazzucconi, F.; Gatti, E. Soy and cholesterol reduction: Clinical experience. J. Nutr. 1995, 125, 598S-605S.
11. Jenkins, D.J.; Mirrahimi, A.; Srichaikul, K.; Berryman, C.E.; Wang, L.; Carleton, A.; Abdulnour, S.; Sievenpiper, J.L.; Kendall, C.W.; Kris-Etherton, P.M. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J. Nutr. 2010, 140, 2302S-2311S.
12. Aoyama, T.; Kohno, M.; Saito, T.; Fukui, K.; Takamatsu, K.; Yamamoto, T.; Hashimoto, Y.; Hirotsuka, M.; Kito, M. Reduction by phytate-reduced soybean beta-conglycinin of plasma triglyceride level of young and adult rats. Biosci. Biotechnol. Biochem. 2001, 65, 1071-1075.
13. Moriyama, T.; Kishimoto, K.; Nagai, K.; Urade, R.; Ogawa, T.; Utsumi, S.; Maruyama, N.; Maebuchi, M. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci. Biotechnol. Biochem. 2004, 68, 352-359.
14. Kohno, M.; Hirotsuka, M.; Kito, M.; Matsuzawa, Y. Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin. J. Atheroscler. Thromb. 2006, 13, 247-255.
15. Kirk, E.A.; Sutherland, P.; Wang, S.A.; Chait, A.; LeBoeuf, R.C. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J. Nutr. 1998, 128, 954-959.
16. Kishida, T.; Mizushige, T.; Nagamoto, M.; Ohtsu, Y.; Izumi, T.; Obata, A.; Ebihara, K. Lowering effect of an isoflavone-rich fermented soybean extract on the serum cholesterol concentrations in female rats, with or without ovariectomy, but not in male rats. Biosci. Biotechnol. Biochem. 2006 70, 1547-1556.
17. Greaves, K.A.; Wilson, M.D.; Rudel, L.L.; Williams, J.K.; Wagner, J.D. Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J. Nutr. 2000, 130, 820-826.
18. Yamakoshi, J.; Piskula, M.K.; Izumi, T.; Tobe, K.; Saito, M.; Kataoka, S.; Obata, A.; Kikuchi, M. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J. Nutr. 2000, 130, 1887-1893.
19. Shukla, A.; Brandsch, C.; Bettzieche, A.; Hirche, F.; Stangl, G.I.; Eder, K. Isoflavone-poor soy protein alters the lipid metabolism of rats by SREBP-mediated down-r regulation of hepatic genes. J. Nutr. Biochem. 2007, 18, 313-321.
20. Fukui, K.; Tachibana, N.; Fukuda, Y.; Takamatsu, K.; Sugano, M. Ethanol washing does not attenuate the hypocholesterolemic potential of soy protein. Nutrition 2004, 20, 984-990.
21. McVeigh, B.L.; Dillingham, B.L.; Lampe, J.W.; Duncan, A.M. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am. J. Clin. Nutr. 2006, 83, 244-251.
22. Goodman-Gruen, D.; Kritz-Silverstein, D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J. Nutr. 2001, 131, 1202-1206.
23. Zhuo, X.G.; Melby, M.K.; Watanabe, S. Soy isoflavone intake lowers serum LDL cholesterol: A meta-analysis of 8 randomized controlled trials in humans. J. Nutr. 2004, 134, 2395-2400.
24. Zhan, S.; Ho, S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 2005, 81, 397-408.
25. Taku, K.; Umegaki, K.; Sato, Y.; Taki, Y.; Endoh, K.; Watanabe, S. Soy isoflavones lower serum total and LDL cholesterol in humans: A meta-analysis of 11 randomized controlled trials. Am. J. Clin. Nutr. 2007, 85, 1148-1156.
26. Chun, J.; Kim, G.M.; Lee, K.W.; Choi, I.D.; Kwon, G.H.; Park, J.Y.; Jeong, S.J.; Kim, J.S.; Kim, J.H. Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. J. Food Sci. 2007, 72, M39-M44.
27. Izumi, T.; Piskula, M.K.; Osawa, S.; Obata, A.; Tobe, K.; Saito, M.; Kataoka, S.; Kubota, Y.; Kikuchi, M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 2000, 130, 1695-1699.
28. Kobayashi, M.; Harada, T.; Takagi, N.; Tsuzuki, K.; Sugawara, M.; Fukuda, M. Effects of lactic acid-fermented soymilk on lipid metabolism-related gene expression in rat liver. Biosci. Biotechnol. Biochem. 2012, 76, 19-24.
29. Kobayashi, M.; Hirahata, R.; Egusa, S.; Fukuda, M. Hypocholesterolemic effects of lactic acid-fermented soymilk on rats fed a high cholesterol diet. Nutrients 2012, 4, 1304-1316.
30. Hirahata, R.; Kobayashi, M.; Egusa, S.; Sakakibara, R.; Fukuda, M. Effects of fermented soymilk on lipid metabolism in rats fed a high fat diet. Nippon Shokuhin Kagaku Kogaku Kaishi 2012, 59, 528-532. (In Japanese)
31. Hirahata, R.; Kobayashi, M.; Egusa, S.; Sakakibara, R.; Fukuda, M. Lactic fermented soymilk improves hepatic lipid metabolism in rats fed a high fat and high cholesterol diet. Nippon Shokuhin Kagaku Kogaku Kaishi 2013, 60, 72-79. (In Japanese)
32. Kobayashi, M.; Sakakibara, R.; Egusa, S.; Fukuda, M. Effects of isoflavone aglycone ratio in lactic acid-fermented soymilk on hepatic lipid metabolism in rats fed a high fat and high cholesterol diet. Nippon Shokuhin Kagaku Kogaku Kaishi 2013, 60, 509-515. (In Japanese)
33. Thorp, A.A.; Howe, P.R.; Mori, T.A.; Coates, A.M.; Buckley, J.D.; Hodgson, J.; Mansour, J.; Meyer, B.J. Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. Am. J. Clin. Nutr. 2008, 88, 298-304.
34. Wong, J.M.; Kendall, C.W.; Marchie, A.; Liu, Z.; Vidgen, E.; Holmes, C.; Jackson, C.J.; Josse, R.G.; Pencharz, P.B.; Rao, A.V.; et al. Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods. Am. J. Clin. Nutr. 2012, 95, 564-571.
35. Reeves, P.G.; Nielsen, F.H.; Fahey, G.C. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1951.
36. Folch, J.; Lees, M.; Sloane Stanley, G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
37. Myant, N.B.; Mitropoulos, K.A. Cholesterol 7 alpha-hydroxylase. J. Lipid Res. 1977, 18, 135-153.
38. Chen, J.; Raymond, K. Nuclear receptors, bile-acid detoxification, and cholestasis. Lancet 2006, 367, 454-456.
39. Horton, J.D.; Shimomura, I.; Brown, M.S.; Hammer, R.E.; Goldstein, J.L.; Shimano, H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Investig. 1998, 101, 2331-2339.
40. Shin, E.S.; Lee, H.H.; Cho, S.Y.; Park, H.W.; Lee, S.J.; Lee, T.R. Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells. J. Nutr. 2007, 137, 1127-1131.
41. Joseph, S.B.; Laffitte, B.A.; Patel, P.H.; Watson, M.A.; Matsukuma, K.E.; Walczak, R.; Collins, J.L.; Osborne, T.F.; Tontonoz, P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 2002, 277, 11019-11025.
42. Mullen, E.; Brown, R.M.; Osborne, T.F.; Shay, N.F. Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and SREBP-regulated genes in HepG2 cells. J. Nutr. 2004, 134, 2942-2947.
43. Fukui, K.; Tachibana, N.; Wanezaki, S.; Tuzaki, S.; Kiyoharu, T.; Yamamoto, T.; Hashimoto, Y.; Shimoda, T. Isoflavone-free soy protein prepared by column chromatography reduces plasma cholesterol in rats. J. Agric. Food Chem. 2002, 50, 5717-5721.
44. Sato, R.; Inoue, J.; Kawabe, Y.; Kodama, T.; Takano, T.; Maeda, M. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 1996, 271, 26461-26464.
45. Vallett, S.M.; Sanchez, H.B.; Rosenfeld, J.M; Osborne, T.F. A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene. J. Biol. Chem. 1996, 271, 12247-12253.
46. Baum, J.A.; Teng, H.; Erdman, J.W.; Weigel, R.M.; Klein, B.P.; Persky, V.W.; Freels, S.; Surya, P.; Bakhit, R.M.; Ramos, E.; et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterlemic, postmenopausal women. Am. J. Clin. Nutr. 1998, 68, 545-551.
47. McGarry, J.D.; Sen, A.; Esser, V.; Woeltje, K.F.; Weis, B.; Foster, D.W. New insights into the mitochondrial carnitine palmitoyltransferase enzyme system. Biochimie 1991, 73, 77-84.
48. Kanamoto, R.; Inai, M.; Miyaki, W. Physiological function and its mechanism of soybean lipophilic protein as a functional food for prevention of metabolic syndrome. Soy Protein Res. Jpn. 2008, 11, 75-81.